NCT05867602View on ClinicalTrials.gov

High Dose Albumin in Refractory Ascites

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

March 25, 2026

Study Completion Date

June 25, 2026

Conditions
Ascites
Interventions
DRUG

Albumin

intravenous human albumin at a dose of (1g/kg), with a minimum dose of 50g and a maximum dose of 100g

Trial Locations (1)

77030

RECRUITING

Baylor St' Lukes Medical center, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER